Abu Dhabi Eyes More Deals to Build AI-Powered Global Health Firm
- M42’s first deal was $2.5 billion Diaverum acquisition in 2023
- Oil-rich emirate is investing billions in AI initiatives
This article is for subscribers only.
One of Abu Dhabi’s newest state-backed investment companies is looking at dozens of potential new deals as it plans to build an artificial intelligence-powered healthcare champion that it can expand across the world.
M42, which was established through the combination of the healthcare assets of two of Abu Dhabi’s investment firms last year, is eying potential acquisitions and expansions of its operations into Europe, Latin America and Asia, according to chief executive officer Hasan Jasem Al Nowais.